Pancreatic Cancer Research

ResearcherCatholic University of KoreaActive in the last 2 years

Moon Hyung Choi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5962-4772; OpenAlex author ID A5029495151. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 11

  1. Conversion of Mixed-Language Free-Text CT Reports of Pancreatic Cancer to National Comprehensive Cancer Network Structured Reporting Templates by Using GPT-4. Co-author DOI 10.3348/kjr.2024.1228↗
  2. Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and next-generation sequencing. Co-author DOI 10.3389/fonc.2024.1304187↗
  3. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis. Co-author DOI 10.1007/s00330-023-09959-5↗
  4. Evaluation of Perfusion Change According to Pancreatic Cancer and Pancreatic Duct Dilatation Using Free-Breathing Golden-Angle Radial Sparse Parallel (GRASP) M… Co-author DOI 10.3390/diagnostics13040731↗
  5. Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer. Co-author DOI 10.3390/biomedicines10061289↗
  6. Sarcopenia in pancreatic cancer: Effect on patient outcomes. Co-author DOI 10.4251/wjgo.v14.i12.2302↗
  7. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observat… First author DOI 10.1186/s12885-020-07753-w↗
  8. Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography. Co-author DOI 10.1371/journal.pone.0240318↗
  9. MRI of pancreatic ductal adenocarcinoma: texture analysis of T2-weighted images for predicting long-term outcome. Co-author DOI 10.1007/s00261-018-1681-2↗
  10. Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer. Co-author DOI 10.1002/jcsm.12274↗
  11. Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III? Co-author DOI 10.1016/j.ejca.2018.08.027↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Seung Bae Yoon · 9 shared papers, 2018–2024 · strength 1.60
  2. In Seok Lee · 5 shared papers, 2018–2022 · strength 0.63
  3. Myung Ah Lee · 5 shared papers, 2018–2022 · strength 0.63
  4. Tae Ho Hong · 5 shared papers, 2018–2022 · strength 0.63
  5. Eun Sun Jung · 4 shared papers, 2018–2024 · strength 0.61
  6. Dongyeob Han · 2 shared papers, 2023–2024 · strength 0.51
  7. Sung Eun Rha · 2 shared papers, 2019–2025 · strength 0.42
  8. Hokun Kim · 1 shared paper, 2025 · strength 0.30
  9. Bohyun Kim · 1 shared paper, 2025 · strength 0.30
  10. Meiying Song · 3 shared papers, 2018–2020 · strength 0.29
  11. Ho Joong Choi · 2 shared papers, 2018–2022 · strength 0.25
  12. Dominik Marcel Nickel · 1 shared paper, 2024 · strength 0.24
  13. Dong Woo Shin · 1 shared paper, 2023 · strength 0.19
  14. Min-Jeong Kim · 1 shared paper, 2023 · strength 0.19
  15. Tae Yeon Jeon · 1 shared paper, 2023 · strength 0.19
  16. Sung‐Hoon Moon · 1 shared paper, 2023 · strength 0.19
  17. Ji Hye Min · 1 shared paper, 2023 · strength 0.19
  18. Sang Min Lee · 1 shared paper, 2023 · strength 0.19
  19. In-Ho Kim · 1 shared paper, 2021 · strength 0.17
  20. Young Hoon Choi · 1 shared paper, 2022 · strength 0.16
  21. Seung Eun Jung · 1 shared paper, 2019 · strength 0.11
  22. Myung‐Gyu Choi · 1 shared paper, 2018 · strength 0.09
  23. Myung‐Gyu Choi · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.